Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

By N. Colombo, E. Preti, F. Landoni, S. Carinelli, A. Colombo, C. Marini, C. Sessa. Annals of Oncology, 2011

610 citations recorded by the source corpus.

Subfields: Obstetrics and Gynecology, Reproductive Medicine

View Paper: https://www.semanticscholar.org/paper/f777f7bb7385caf01110f059199c9244710975dd

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Obstetrics and Gynecology

In Reproductive Medicine

Citations in the corpus

Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer (2017, result): “Second, we wanted to compare the prognostic ability of ProMisE to traditional risk-stratification system commonly used to direct treatment (European Society for Medical Oncology [ESMO]).(12)”
Erratum to: Endometrial Cancer (2017, background): “Serous and clear-cell carcinomas can occur in atrophic endometrium and may present with distant disease even without myometrial invasion; therefore, omentectomy, diaphragmatic cytology or biopsy, and random peritoneal biopsies should be performed (Koh et al. 2014; Colombo et al. 2013).”
A clinically applicable molecular-based classification for endometrial cancers (2015, methodology): “…risk group stratification that is based on stage and the irreproducible variables of grade and histotype assignment (Fanning, 2001; Keys et al, 2004; Mariani et al, 2008; Kwon et al, 2009; Colombo et al, 2013; Kong et al, 2015), and is not highly predictive of outcomes (Bendifallah et al, 2015).”
ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up. (2015, methodology): “Given the large body of literature available that addresses the management of endometrial cancer, the aim of this consensus conference was to produce multidisciplinary evidence-based guidelines on selected clinically-relevant questions in order to complement the already-available European Society fo”
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer (2015, background): “However, these additional recommendations for specific clinical situations should be read in conjunction with the ESMO CPG for the diagnosis, treatment and follow-up of patients with endometrial cancer.(8)”